Ningxia supplies two-vote system came small and medium-sized agents to start looking for a way out

Medical Network May 18 hearing of small agents to start looking for a way outRecently, the Ningxia Hui Autonomous Region People's Government issued "high value medical supplies governance reform plan" (hereinafter referred to as "embodiment"), a clear request for strengthening the circulation management, to explore the "two votes system "in order to reduce the high value medical supplies circulation, promote open and transparent buying and selling behaviorwhile strengthening market supervision and sampling of the circulation of high value medical supplies, medical supplies, promote high value-related companies and their employees credit commitments, establish and improve related subjects imputation credit information systemIn addition, the Insurance Bureau of Fujian Province recently released the "Fujian concentrate with a volume of medical supplies procurement documents (draft)", will have heart stents, artificial joints, indwelling needles, scalpel, analgesia 5 a total of 17 categories and other medical supplies with the amount centralized purchasingalso asked selected with the amount of medical supplies centralized procurement strictly enforce the "two votes" system, to encourage the implementation of "one-vote system." Distribution companies should be timely delivery of medical supplies in accordance with the contract and procurement needs of medical institutionsJanuary of this year, Sichuan Province Medical Insurance Bureau also issued "to the public to solicit public opinion," said the public should actively explore the medical institutions in Sichuan Province by "two-vote system" in order to reduce the high value medical supplies circulation, promote open and transparent buying and selling behaviorseen from the beginning of 2020 to date, consumables two-vote system continues steadilyeffect on the two-vote system from the point of viewcirculation in the hospital company's share trend set to large distribution companiesSichuan Dujiangyan People's Hospital had articles published in "Chinese Medicine" magazine, published a set of dataA before a "two-vote" In Embodiment 1, a home delivery company 24 supplying products to the hospital, if the average value is calculated, each company in the procurement share of about 4 %, in fact, each distribution company's share in our hospital in a non-uniform distributionmarket share of more than 4% of the distribution company only eight, and its share of up to 68.68%, and the remaining 16 accounted for only 31.22%A company after a "two-vote system" embodiment, reduced to 2.63% in addition to a distribution of market share, the market share of more than 4% is still the previous seven companies, no other companies to enter, but more significant share distribution to a few large companies focus on the trend, this seven companies share reached 72.03%, the remaining 18 companies, a distribution company to be replaced, reducing the share of the 11 companiesIn addition, the large national distribution companies authorized more variety, after "two votes" system implementation, its advantage is more obvioussuch as accounting and distribution in the amount of two hospitals before Sinopharm southwestCo., Sichuan Pharmaceutical Co., LtdSinopharm belong to the same group of a large pharmaceutical distribution, its share has been " two-vote system "before the implementation rose 28.58% to 32.4%, an increase of the total amount of 13.039 million yuan University School of Pharmacy, Shandong has also published an article analysis, distribution will show a polarized, to improve industry concentration implementation of two-vote system policy is to a large pharmaceutical distribution companies to expand the scale and enhance the strength of the opportunity, through mergers and acquisitions, large-scale circulation enterprises the ability to control critical resources to further strengthen, thereby forming a barrier to potential entrants , but also improve its position as a supplier bargaining power and status in the industry such as Sinopharm Group, China Resources Pharmaceutical, Shanghai Pharmaceutical, Kyushu and other large pharmaceutical distribution companies, both underwent aggressive mergers and acquisitions strategy to Lanshou channels to further expand business scale and strength while for small and medium sized distribution companies, subject to funding and downstream resource constraints, the large-scale circulation enterprises merger or restructuring in order to survive the market to seek new direction of development of small and medium circulation enterprises.